The prognostic role of pretreatment epidermal growth factor receptor T790M mutation in advanced non-small cell lung cancer patients treated with EGFR tyrosine kinase inhibitors

PURPOSE: The outcome of pretreatment epidermal growth factor receptor (EGFR) T790M mutation in EGFR mutant non-small cell lung cancer (NSCLC) patients treated with EGFR tyrosine kinase inhibitors (TKIs) is controversial, this study aimed to evaluate the prognostic role of pretreatment T790M in advan...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Guangzhi, Zhang, Jing, Yin, Liyuan, Jiang, Hai, Zhang, Weiwei, Song, Yanlin, Liu, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584219/
https://www.ncbi.nlm.nih.gov/pubmed/28881618
http://dx.doi.org/10.18632/oncotarget.16222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584219/
https://www.ncbi.nlm.nih.gov/pubmed/28881618
http://dx.doi.org/10.18632/oncotarget.16222

Ejemplares similares